Recently, AUSTAR successfully signed a contract with a biotechnology company in the medical aesthetics industry to provide a preparation system for its 4 production lines and supporting CIP systems, which will be used in its hyaluronic acid production project. In the product development process, our engineering team design services in the conceptual design phase and detailed phase align the client’s corporate standards, preferred plant layout and industry-proven practices with project requirements to formulate a best value design foundation for the project. The professionalism and dedication of the AUSTAR team in the product development process were highly recognized by our client.
AUSTAR has gradually entered into the field of medical devices and medical aesthetics in recent years. The signing of this project signals AUSTAR's further development in the field of medical devices. After the acceptance of the project, AUSTAR is also expected to carry out closer cooperation with the client in other projects.
The company is a high-tech biomedical company focused on the development, production and marketing of medical biomaterials, it strategically focuses on the fast-growing therapeutic segments of the medical biomaterials market, including ophthalmology, cosmetic and wound care, orthopedics, anti-adhesion and hemostasis.